PAM
EBS icon

Paradigm Asset Management’s Emergent Biosolutions EBS Stock Holding History

Paradigm Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,550
Closed -$45K – 606
2017
Q1 		$45K Sell
1,550
-24,050
-94% -$732K 0.01% 578
2016
Q4 		$841K Sell
25,600
-9,600
-27% -$288K 0.16% 113
2016
Q3 		$1.11M Buy
35,200
+13,550
+63% +$394K 0.19% 101
2016
Q2 		$609K Buy
21,650
+15,400
+246% +$604K 0.11% 195
2016
Q1 		$227K Sell
6,250
-6,800
-52% -$240K 0.04% 300
2015
Q4 		$522K Buy
13,050
+100
+0.8% +$3.49K 0.09% 206
2015
Q3 		$369K Buy
+12,950
New +$427K 0.05% 342

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Paradigm Asset Management's EBS Position: Q2 2017 in Review

Paradigm Asset Management sold out of Emergent Biosolutions (EBS) in Q2 2017, closing a stake of 1,550 shares — an estimated $45K sold.

Paradigm Asset Management first reported a position in EBS in Q3 2015 and held it in 7 quarters. The position peaked at $1.11M in Q3 2016. 181 funds tracked by Wall St. Rank hold EBS as of Q2 2017.

  • Paradigm Asset Management reported no remaining Emergent Biosolutions position as of Q2 2017 after selling out during the quarter.
  • Paradigm Asset Management sold 1,550 Emergent Biosolutions shares in Q2 2017, an estimated $45K.
  • Paradigm Asset Management first reported a position in Emergent Biosolutions in Q3 2015 and held it in 7 quarters.
  • Paradigm Asset Management's Emergent Biosolutions position peaked at $1.11M in Q3 2016.
  • 181 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2017.

Based on Paradigm Asset Management's 13F filing for Q2 2017, filed 7 Aug 2017.